LSD: a new treatment emerging from the past
Canadian Medical Association Journal August 4, 2015 DOI: 10.1503/cmaj.141358 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | LSD |
| Keywords | Fell |
| Citations | 25 |
| Key findings | Psychedelics lost medical acceptance about 50 years ago but recent research suggests growing optimism for their therapeutic return; Albert Hofmann first synthesized LSD over 60 years ago. |
Abstract
Psychedelics fell from medical grace nearly half a century ago, but recent activity suggests that some researchers have "high hopes" for their return.[1][1],[2][2] Over 60 years ago, Albert Hofmann at Sandoz Pharmaceutical Laboratories in Switzerland first synthesized lysergic acid diethylamide
Comparable studies
Other narrative reviews on LSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Study of a New Schizophrenomimetic Drug—Sernyl | 1959 | Review | |
| Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. General population | 2019 | Integrative review | |
| The Pharmacology of Lysergic Acid Diethylamide: A Review | 2008 | Review | |
| Serotonin research: contributions to understanding psychoses | 2008 | Review | |
| ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE | 1984 | Review |
Citations in the library
Cited by 18
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults Journal of Psychopharmacology 2022
- Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting BMJ Open September 1, 2017
- Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review. Medicine, Health Care, and Philosophy June 1, 2019
- Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion. Healthcare policy = Politiques de sante May 1, 2023
and 13 more in the library